Tetragon Partners GP Ltd
Source: SEC Form 13F · as of Mar 2026Tetragon Partners GP Ltd holds 18 biotech & pharma companies tracked by BioSniper, totaling $89.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$89.5M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Autolus Therapeutics plc (AUTL)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| AUTLAutolus Therapeutics plc | 9,500,000 | $13.1M |
| CLDXCelldex Therapeutics, Inc. | 312,316 | $9.9M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 127,198 | $8.0M |
| NKTRNEKTAR THERAPEUTICS | 103,037 | $7.4M |
| ANNXAnnexon, Inc. | 1,292,455 | $7.2M |
| PHVSPharvaris N.V. | 221,611 | $6.3M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 164,839 | $5.6M |
| IMVTImmunovant, Inc. | 218,507 | $5.4M |
| DFTXDefinium Therapeutics Inc. | 199,994 | $3.8M |
| SLNOSOLENO THERAPEUTICS INC | 102,125 | $3.4M |
| AXSMAxsome Therapeutics, Inc. | 20,059 | $3.4M |
| SLNSilence Therapeutics Plc | 630,161 | $3.3M |
| ACADACADIA PHARMACEUTICALS INC | 144,620 | $3.2M |
| IONSIONIS PHARMACEUTICALS INC | 41,764 | $3.1M |
| MPLTMapLight Therapeutics, Inc. | 112,115 | $2.3M |
| RLAYRelay Therapeutics, Inc. | 181,543 | $1.8M |
| AARDAardvark Therapeutics, Inc. | 316,621 | $1.2M |
| TECXTectonic Therapeutic, Inc. | 37,588 | $1.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.